Sustainability & Climate

A new poll for America's 250th birthday shows a nation that reveres its Founders but has abandoned their core beliefs on rights and government.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

Celcuity prepares for a key fireside chat at Guggenheim's 2026 summit, with investors eyeing crucial updates on its lead cancer drug, gedatolisib.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?

With promising new pipeline data and a major earnings report looming, Aclaris Therapeutics heads to two investor summits, placing its strategy on display.

Fueled by strong investor demand, Meridian Mining has upsized its financing to C$50 million, accelerating its high-potential Cabaçal project in Brazil.

Final Phase 1b data for Kodiak Sciences' KSI-101 suggests a potential breakthrough for macular edema, a condition lacking dedicated biologic therapies.

GE Aerospace's massive investment will create an AI-powered MRO hub, promising faster, smarter engine repairs and reshaping Asia's aviation landscape.

Markets are calm, but concerns over US Federal Reserve independence add a new layer of risk to global trade, threatening borrowing costs and stability.

A new six-month injection for Central Precocious Puberty shows strong safety and efficacy, promising to ease the treatment burden for children and families.

HOTELEX Shanghai 2026 debuts 'The Bar & Drinks Shanghai,' an immersive platform tapping into Asia’s premium beverage and experiential drinking revolution.

Registration is open for Asia's massive food trade fair, where 180,000+ pros will discover the future of food and forge new global partnerships.

A new review calls Webroot a top VPN, but independent tests and affiliate marketing models tell a more complex story. Here's what you need to know.

As the FDA embraces advanced Bayesian statistics, MedTech firm BioStem sees validation for its wound care research, promising faster innovation for patients.

Ottawa prepares to unveil a sweeping plan for a digitally connected health system, promising better care but facing major hurdles in privacy and security.

Amidst economic headwinds, JD Power projects 16.3M vehicle sales for 2026 and launches its new 'Power Platform' to help the industry navigate disruption.

EXL has been named a leader in healthcare for the fourth year. We explore how its data and AI strategy is driving efficiency and better patient outcomes.

A new analysis of malpractice claims reveals the top drivers of patient harm in cardiology, offering critical insights to save lives and protect careers.

The tire giant's latest deal for a sealing specialist signals an aggressive push into high-value materials, moving far beyond its rubber-and-road legacy.

As Erie prepares its 2025 results, investors eye underwriting profit, premium growth, and future guidance in a turbulent insurance market.